Biogen And Sage On Plans To Build A Brain Franchise Together

 
• By Jessica Merrill

The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.

Colorful low poly side view brain illustration isolated on blue background
Biogen and Sage are partnered on two drugs for psychiatric disorders • Source: Shutterstock

More from Deals

More from Business